| scholarly article | Q13442814 |
| P50 | author | Daniel S Berman | Q89697826 |
| P2093 | author name string | Guido Germano | |
| Piotr J Slomka | |||
| Aloha Meave | |||
| Erick Alexanderson | |||
| Ludovic Le Meunier | |||
| Heinrich Schelbert | |||
| Rodrigo Jácome | |||
| Edgar Romero | |||
| Magnus Dalhbom | |||
| Moises Jiménez | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 171-181 | |
| P577 | publication date | 2012-01-06 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | Comparison of clinical tools for measurements of regional stress and rest myocardial blood flow assessed with 13N-ammonia PET/CT. | |
| P478 | volume | 53 |
| Q85709063 | Absolute myocardial blood flow quantification with SPECT/CT: is it possible? |
| Q37360861 | Absolute myocardial flow quantification with (82)Rb PET/CT: comparison of different software packages and methods |
| Q57622205 | Advances in clinical application of quantitative myocardial perfusion imaging |
| Q36480156 | Automatic alignment of myocardial perfusion PET and 64-slice coronary CT angiography on hybrid PET/CT. |
| Q36081581 | CFR and FFR assessment with PET and CTA: strengths and limitations |
| Q49833445 | Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. |
| Q38723494 | Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM). |
| Q34310203 | Comparison of the Cardiac MicroPET Images Obtained Using [(18)F]FPTP and [(13)N]NH3 in Rat Myocardial Infarction Models |
| Q47557715 | Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy |
| Q45365613 | Computed tomography calcium score scan for attenuation correction of N-13 ammonia cardiac positron emission tomography: effect of respiratory phase and registration method |
| Q37375799 | Effect of Bayesian-penalized likelihood reconstruction on [13N]-NH3 rest perfusion quantification. |
| Q42659518 | Fully quantitative cardiovascular magnetic resonance myocardial perfusion ready for clinical use: a comparison between cardiovascular magnetic resonance imaging and positron emission tomography |
| Q50012538 | Lost in quantification…: The influence of different software packages on flow quantification measures |
| Q88160060 | Motion Correction and Its Impact on Absolute Myocardial Blood Flow Measures with PET |
| Q42399257 | Myocardial blood flow from SPECT |
| Q36903472 | Myocardial blood flow quantification by Rb-82 cardiac PET/CT: A detailed reproducibility study between two semi-automatic analysis programs |
| Q33651049 | Myocardial flow reserve (MFR) with positron emission tomography (PET)/computed tomography (CT): clinical impact in diagnosis and prognosis |
| Q52573262 | Myocardial flow reserve derived by dynamic perfusion single-photon emission computed tomography reflects the severity of coronary atherosclerosis. |
| Q36834147 | Myocardial perfusion imaging with PET |
| Q59515630 | Myocardial perfusion imaging with PET |
| Q43848606 | Myocardial perfusion models: a means or an end? |
| Q52982217 | PET-measured longitudinal flow gradient correlates with invasive fractional flow reserve in CAD patients. |
| Q38021718 | PET: Is myocardial flow quantification a clinical reality? |
| Q35047860 | Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography |
| Q38418567 | Precision and accuracy of clinical quantification of myocardial blood flow by dynamic PET: A technical perspective. |
| Q38023739 | Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be? |
| Q34660562 | Quantification of myocardial blood flow in absolute terms using (82)Rb PET imaging: the RUBY-10 Study |
| Q37288099 | Quantitative cardiac positron emission tomography: the time is coming! |
| Q38682632 | Reasons and implications of agreements and disagreements between coronary flow reserve, fractional flow reserve, and myocardial perfusion imaging |
| Q37082612 | Relationship Between Quantitative Adverse Plaque Features From Coronary Computed Tomography Angiography and Downstream Impaired Myocardial Flow Reserve by 13N-Ammonia Positron Emission Tomography: A Pilot Study |
| Q50067270 | Reporting myocardial flow reserve with PET. Ready or not, here it is! But walk before you fly! |
| Q37339320 | Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software |
| Q40492999 | Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal |
| Q38985171 | SPECT and PET in ischemic heart failure. |
| Q39906610 | Segmental quantitative myocardial perfusion with PET for the detection of significant coronary artery disease in patients with stable angina. |
| Q34289892 | Short-term repeatability of resting myocardial blood flow measurements using rubidium-82 PET imaging |
| Q58610989 | Simplified quantification PET myocardial blood flow: The need for technical standardization |
| Q40562079 | Stress myocardial blood flow correlates with ventricular function and synchrony better than myocardial perfusion reserve: A Nitrogen-13 ammonia PET study. |
| Q52594732 | The continual innovation of commercial PET/CT solutions in nuclear cardiology: Siemens Healthineers. |
| Q86940500 | The reproducibility of time-of-flight PET and conventional PET for the quantification of myocardial blood flow and coronary flow reserve with (13)N-ammonia |
| Q40655323 | The role of PET quantification in cardiovascular imaging |
| Q62711621 | Value Based Imaging for Coronary Artery Disease: Implications for Nuclear Cardiology and Cardiac CT |
Search more.